Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-09

FDA Approved: DOFETILIDE — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approves NorthStar RxLLC's generic dofetilide for the maintenance of normal sinus rhythm in adults with atrial fibrillation or atrial flutter (ANDA 210466).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dofetilide (dofetilide)

Snippet

ORIG AP for DOFETILIDE (DOFETILIDE)